Related Experiment Video
Updated: Jan 23, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders
Marie Vincent1,2, Justyna A Karolak3,4, Gail Deutsch5
1Service de Genetique Medicale, Centre Hospitalier Universitaire de Nantes, Nantes, France.
Lethal lung developmental disorders in infants are challenging to diagnose. Whole-genome sequencing can improve diagnostic accuracy for these rare pediatric respiratory conditions.
Area of Science:
- Pediatric Pulmonology
- Medical Genetics
- Developmental Biology
Background:
- Lethal lung developmental disorders present as neonatal respiratory failure.
- Histopathological diagnosis is challenging due to overlapping features.
- Genetic underpinnings of some disorders, like alveolar capillary dysplasia, are known, but others remain unclear.
Purpose of the Study:
- To investigate the molecular basis of acinar dysplasia and congenital alveolar dysplasia.
- To highlight the role of noncoding regulatory elements in human lung development.
- To propose an improved diagnostic pathway for lethal lung developmental disorders.
Main Methods:
- Review of genetic studies on lethal lung developmental disorders.
- Application of next-generation sequencing techniques (exome and whole-genome sequencing).
- Analysis of the TBX4-FGF10-FGFR2 signaling pathway.
Main Results:
- Identified disruption of the TBX4-FGF10-FGFR2 pathway in acinar and congenital alveolar dysplasia.
- Demonstrated complex compound inheritance patterns.
- Confirmed the critical role of noncoding regulatory elements in lung development.
Conclusions:
- Noncoding regulatory elements are crucial for human lung development.
- Whole-genome sequencing should be integrated into diagnostic protocols for these disorders.
- Improved diagnostics can inform recurrence risk assessment.
More Related Videos
05:56Author Spotlight: Enhancing Diagnostic Strategies and Biomarker Development for Comprehensive Lung Function Analysis
Published on: August 9, 2024
09:45Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease
Published on: April 12, 2021
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Mitral Stenosis II: Clinical features and Diagnostic Tests